Clinical Trials
3 trialsNCT01435369 2016-01-21
Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Medivation, Inc.
Phase 2 Completed
NCT00890305 2015-07-08
Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
Medivation, Inc.
Phase 2 Completed
NCT00532259 2014-09-12
CT-011 MAb in DLBCL Patients Following ASCT
CureTech Ltd
Phase 2 Completed